Husseini Manji - 02 Jan 2025 Form 4 Insider Report for Alto Neuroscience, Inc. (ANRO)

Role
Director
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
Issuer symbol
ANRO
Transactions as of
02 Jan 2025
Net transactions value
+$44,998
Form type
4
Filing time
06 Jan 2025, 16:17:45 UTC
Previous filing
05 Feb 2024
Next filing
15 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANRO Stock Option (right to buy) Award $44,998 +14,195 $3.17 14,195 02 Jan 2025 Common Stock 14,195 $4.38 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 3,548 shares underlying the option shall vest on March 31, 2025, and 3,549 shares underlying the option shall vest on each of June 30, 2025, September 30, 2025 and December 31, 2025, subject to the Reporting Person's continuous service through each such vesting date.
F2 This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $45,000.